About Magellan BioScience Group
Magellan BioScience Group is a company based in Tampa (United States) founded in 1997 was acquired by Meridian Bioscience in March 2016. Magellan BioScience Group has raised $25 thousand across 2 funding rounds from investors including Meridian Bioscience, NIH and Florida High Tech Corridor. Magellan BioScience Group has completed 1 acquisition, including TREK Diagnostic Systems. Magellan BioScience Group offers products and services including Microbial Strains Library and Pure Peptide Library. Magellan BioScience Group operates in a competitive market with competitors including AnalytiCon Discovery, C2 Pharma, Celtarys, BJ Biochem and Metagreen, among others.
- Headquarter Tampa, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Magellan Bioscience Group Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$25 K (USD)
in 2 rounds
-
Latest Funding Round
$25 K (USD), Unspecified
Sep 17, 2012
-
Investors
Meridian Bioscience
& 2 more
-
Employee Count
Employee Count
- Investments & Acquisitions
-
Acquired by
Meridian Bioscience
(Mar 24, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Magellan BioScience Group
Magellan BioScience Group offers a comprehensive portfolio of products and services, including Microbial Strains Library and Pure Peptide Library.
Collection of over 10,000 microbial strains for drug discovery studies.
Over 2400 pure peptides for high-throughput screening assays.
Funding Insights of Magellan BioScience Group
Magellan BioScience Group has successfully raised a total of $25K across 2 strategic funding rounds. The most recent funding activity was a Unspecified round of $25 thousand completed in September 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Unspecified — $25,000
-
First Round
First Round
(06 Jul 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2012 | Amount | Unspecified - Magellan BioScience Group | Valuation |
investors |
|
| Jul, 2007 | Amount | Grant - Magellan BioScience Group | Valuation |
investors |
Investors in Magellan BioScience Group
Magellan BioScience Group has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Meridian Bioscience, NIH and Florida High Tech Corridor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
The Florida High Tech Corridor is focused on regional high-tech development.
|
Founded Year | Domain | Location | |
|
Molecular diagnostic device and kits
|
Founded Year | Domain | Location |
Investments & Acquisitions by Magellan BioScience Group
Magellan BioScience Group has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include TREK Diagnostic Systems.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Offers microbiology solution
|
1999 |
Financial Statements - Magellan BioScience Group
Magellan Bioscience Group Comparisons
Competitors of Magellan BioScience Group
Magellan BioScience Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AnalytiCon Discovery, C2 Pharma, Celtarys, BJ Biochem and Metagreen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Natural products chemistry is specialized in by AnalytiCon Discovery.
|
|
| domain | founded_year | HQ Location |
Manufactures and distributes active pharmaceutical ingredients and compounds worldwide.
|
|
| domain | founded_year | HQ Location |
Company that develops and commercializes novel fluorescent probes and ligands for fluorescence-based methods in drug discovery
|
|
| domain | founded_year | HQ Location |
Research and development services for sugar derivatives are provided.
|
|
| domain | founded_year | HQ Location |
Develops technologies to harness compounds from natural production.
|
Latest news on Magellan Bioscience Group
Frequently Asked Questions about Magellan BioScience Group
Magellan BioScience Group was founded in 1997 and raised its 1st funding round 10 years after it was founded.
Magellan BioScience Group is headquartered in Tampa, United States. It is registered at Tampa, Florida, United States.
Magellan BioScience Group is a funded company, having raised a total of $25K across 2 funding rounds to date. The company's 1st funding round was a Grant of $350K, raised on Jul 06, 2007.
Founded in 1997 and based in Tampa, United States, Magellan BioScience Group operates in the biotechnology sector, focusing on microbial natural products. Research libraries with diverse compounds are offered for applications in pharmaceuticals, agrochemicals, specialty chemicals, and animal health care. Services such as microbial biotransformation, synthetic modifications, and structure elucidation are provided, along with separation and spectroscopic analysis. Partnerships have been established with organizations including BioFlorida, AndroBioSys, and Kemin Pharmaceuticals.
Magellan BioScience Group's top competitors include AnalytiCon Discovery, BJ Biochem and Bicoll.
Magellan BioScience Group offers Microbial Strains Library and Pure Peptide Library.
Magellan BioScience Group has made 1 acquisition, including TREK Diagnostic Systems.
Magellan BioScience Group has 3 investors. Key investors include Meridian Bioscience, NIH, and Florida High Tech Corridor.